Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Clinical Trial

Research Support, Non-U.S. Gov't

Clinical Trial, Phase II

Review

Research Support, U.S. Gov't, P.H.S.

Comparative Study

Case Reports

Research Support, N.I.H., Extramural

Multicenter Study

Letter

Clinical Trial, Phase I

Observational Study

Publication Year

From

Quick links

Individual year

2024

2021

2016

2015

2010

2009

2008

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Oligodendroglioma""[mesh_terms]

23 Results

Searching titles within these results

The role of surgery in grade II/III oligodendroglial tumors.

Niklas Thon, Friedrich-Wilhelm Kreth, Joerg-Christian Tonn

CNS oncology 2016;4(5):317-23

Free Full Text

Abstract

Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.

Siang Liao Lee, Albert Wong, James A Stadler, Jamal McClendon, Timothy R Smith, Nitin R Wadhwani, Tadanori Tomita

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2015;31(1):147-53

Full Text

Abstract

Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma?

Christopher L-H Huang, Hengrui Liu, Jieling Weng, Antony P Jackson

Functional & integrative genomics 2024;24(5):162

Full Text

Abstract

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

Juan Manuel Sepúlveda-Sánchez, Miguel Gil-Gil, Miriam Alonso-García, María Ángeles Vaz Salgado, Elena Vicente, Carlos Mesía Barroso, Ángel Rodríguez Sánchez, Gema Durán, Ramón De Las Peñas, José Muñoz-Langa, Guillermo Velasco, Aurelio Hernández-Laín, Amaya Hilario, Miguel Navarro Martín, Manuel Benavides, Laura Oleaga, Diana Cantero Montenegro, Yolanda Ruano, Pilar Sánchez-Gómez, María Cruz Martín-Soberón, Robert Morales-Llombart, Vanessa Pachón, Estela Pineda

Targeted oncology 2021;15(5):613-622

Full Text

Abstract

High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications.

F Giammarile, L E Cinotti, A Jouvet, J M Ramackers, G Saint Pierre, P Thiesse, E Jouanneau, J Guyotat, I Pelissou-Guyotat, A Setiey, J Honnorat, D Le Bars, D Frappaz

Journal of neuro-oncology 2004;68(3):263-74

Full Text

Abstract

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

Bradford A Moffat, Thomas L Chenevert, Theodore S Lawrence, Charles R Meyer, Timothy D Johnson, Qian Dong, Christina Tsien, Suresh Mukherji, Douglas J Quint, Stephen S Gebarski, Patricia L Robertson, Larry R Junck, Alnawaz Rehemtulla, Brian D Ross

Proceedings of the National Academy of Sciences of the United States of America 2005;102(15):5524-9

Free Full Text

Abstract

CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma.

Marc C Chamberlain, Michael J Glantz

Journal of neuro-oncology 2008;89(2):231-8

Full Text

Abstract

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

David A Reardon, Gamal Akabani, R Edward Coleman, Allan H Friedman, Henry S Friedman, James E Herndon, Ilkcan Cokgor, Roger E McLendon, Charles N Pegram, James M Provenzale, Jennifer A Quinn, Jeremy N Rich, Lorna V Regalado, John H Sampson, Timothy D Shafman, Carol J Wikstrand, Terence Z Wong, Xiao-Guang Zhao, Michael R Zalutsky, Darell D Bigner

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1389-97

Full Text

Abstract

Oligodendroglioma.

Thomas L Ellis, Volker W Stieber, Rebekah C Austin

Current treatment options in oncology 2004;4(6):479-90

Full Text

Abstract

hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas.

M J Bello, J M de Campos, J Vaquero, P Ruiz-Barnés, M E Kusak, J L Sarasa, J A Rey

Cancer genetics and cytogenetics 2000;116(2):142-7

Full Text

Abstract

Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.

A U Ty, S J See, J P Rao, J B K Khoo, M C Wong

Neurology 2006;66(2):247-9

Full Text

Abstract

Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).

Stephen B Hunter, Daniel J Brat, Jeffrey J Olson, Andreas Von Deimling, Wei Zhou, Erwin G Van Meir

International journal of oncology 2004;23(4):857-69

Full Text

Abstract

Radioiodinated (I-125) monoclonal antibody 425 in the treatment of high grade glioma patients: ten-year synopsis of a novel treatment.

Jacqueline G Emrich, Luther W Brady, Tony S Quang, Reiner Class, Curtis Miyamoto, Perry Black, Ulrich Rodeck

American journal of clinical oncology 2003;25(6):541-6

Full Text

Abstract

Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas.

Marc C Chamberlain

Journal of neuro-oncology 2003;59(2):157-63

Full Text

Abstract

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

J Streffer, M Schabet, M Bamberg, E H Grote, R Meyermann, K Voigt, J Dichgans, M Weller

Journal of neurology 2000;247(4):297-302

Full Text

Abstract

Results: 1 – 15 / 23

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Oligodendroglioma""[mesh_terms]

The role of surgery in grade II/III oligodendroglial tumors.

Cranial and spinal oligodendrogliomatosis: a case report and review of the literature.

Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma?

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications.

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma.

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

Oligodendroglioma.

hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas.

Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.

Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).

Radioiodinated (I-125) monoclonal antibody 425 in the treatment of high grade glioma patients: ten-year synopsis of a novel treatment.

Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas.

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

Results for
""Oligodendroglioma""[mesh_terms]